Escitalopram Oxalate

Overview

Escitalopram Oxalate is an antidepressant belonging to the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and generalized anxiety disorder.

API suppliers (31)

Suppliers of Escitalopram Oxalate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• JUBILANT BIOSYS LTDIndia4 active DMF
• APITORIA PHARMA PRIVATE LTDIndia3 active DMF GMP on record
• Cipla USA, Inc.USA3 active DMF
• MATRIX PHARMACORP PRIVATE LTDIndia2 active DMF
• ARCH PHARMALABS LTDIndia2 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China2 active DMF GMP on record
• Hetero Drugs LimitedIndia2 active DMF GMP on record
• Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
• Zydus Lifesciences LimitedIndia1 active DMF GMP on record
• Neuland Laboratories LimitedIndia1 active DMF
• Cadila Pharmaceuticals LimitedIndia1 active DMF GMP on record
• H LUNDBECK AS1 active DMF
• Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
• Micro Labs Usa1 active DMF
• RAKS PHARMA PVT LTDIndia1 active DMF
• VIRUPAKSHA ORGANICS LTDIndia1 active DMF
• WUXI JIDA PHARMACEUTICAL CO LTD1 active DMF
• SHODHANA LABORATORIES PRIVATE LTD1 active DMF
• SMS Pharmaceuticals limitedIndia1 active DMF GMP on record
• Zhejiang Haisen Pharmaceutical Co., Ltd.China1 active DMF
• SYNERGENE ACTIVE INGREDIENTS PRIVATE LTD1 active DMF
• Maithri Laboratories Private LimitedIndia1 active DMF GMP on record
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record
• TOKUYAMA CORP
• FABBRICA ITALIANA SINTETICI SPA

Showing 25 of 31 suppliers — see the full list in the app.

EU CEP holders (15)

Companies holding a valid EU Certificate of Suitability (CEP) for Escitalopram Oxalate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (30 approved US products), the latest listed US patent on Escitalopram Oxalate expires — and exclusivity 16 Sept 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile

Canonical SMILES

CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F

InChIKey

WSEQXVZVJXJVFP-UHFFFAOYSA-N

Therapeutic areas